| Typicality: | 0.523 |
| Saliency: | 0.299 |
| against clinical illness | 15 | transitive-object |
| early in life | 4 | temporal |
| after the second dose | 3 | temporal |
| vaccine → provide → long-term protection | 18 |
| vaccine → confer → long-term protection | 5 |
| vaccine → offer → long-term protection | 4 |
| negative | neutral | positive |
| 0.107 | 0.511 | 0.382 |
| Raw frequency | 27 |
| Normalized frequency | 0.299 |
| Modifier score | 0.950 |
| Perplexity | 25.576 |